Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infectionSARS-CoV-2 감염 치료에 특별히 사용되는 약물의 부작용Review Published on 2020-11-272022-09-11 Journal: Medicina clínica [Category] [DOI] 10.1016/j.medcli.2020.06.019 PMC 바로가기 [Article Type] Review
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19Article Published on 2020-11-202022-10-29 Journal: International Journal of Molecular Sciences [Category] [DOI] 10.3390/ijms21228803 PMC 바로가기 [Article Type] Article
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimabCOVID-19의 내피 손상 및 혈전성 미세혈관병증: 렉틴 경로 억제제 나르소플리맙으로 치료Article Published on 2020-11-012022-09-11 Journal: Immunobiology [Category] [DOI] 10.1016/j.imbio.2020.152001 PMC 바로가기 [Article Type] Article
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactionsReview article Published on 2020-11-012022-10-05 Journal: Pharmacological research [Category] [DOI] 10.1016/j.phrs.2020.105250 [Article Type] Review article
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019코로나바이러스 2019에 렘데시비르를 사용한 간 장애Multicenter Study Published on 2020-11-012022-09-11 Journal: Clinical gastroenterology and hepatology : the off [Category] [DOI] 10.1016/j.cgh.2020.07.050 PMC 바로가기 [Article Type] Multicenter Study
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-10-272022-10-29 Journal: Trials [Category] [DOI] 10.1186/s13063-020-04747-8 PMC 바로가기 [Article Type] Letter
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial중등도의 COVID-19 환자에서 멜라토닌의 효능 및 안전성 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-262022-08-13 Journal: Trials [Category] [DOI] 10.1186/s13063-020-04737-w PMC 바로가기 [Article Type] Letter
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivitiesEditorial Published on 2020-10-012022-10-05 Journal: The Journal of Allergy and Clinical Immunology [Category] [DOI] 10.1016/j.jaci.2020.07.008 [Article Type] Editorial
Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learnedCOVID-19 및 심혈관 부담에 대한 항말라리아 및 세포독성 약물: 문헌 검토 및 배울 교훈Review Published on 2020-07-212022-09-10 Journal: Vascular [Category] [DOI] 10.1177/1708538120941635 PMC 바로가기 [Article Type] Review
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trialArticle Published on 2020-06-072022-10-04 Journal: International immunopharmacology [Category] [DOI] 10.1016/j.intimp.2020.106688 PMC 바로가기 [Article Type] Article